serena williams promoting glp 1 has started media rounds to speak about her weight loss in promotion of the GLP-1 drugs, which are used to treat type 2 diabetes and other conditions. In one ad SerenaWilliams is opening up about

Shaman AM, Bain SC, Bakris G et al (2022) Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER

Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes

Many plans classify semaglutide and tirzepatide as lifestyle drugs rather than medically necessary interventions, forcing patients to choose between their financial security and their health

Novo Nordisk makes both Tresiba and Ozempic (semaglutide)

You'll get valuable resources at no charge

In a study, people have lost an average of nearly 29% of their body weight over about 16 monthsthe highest result seen for any weight-loss medication to date